STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Not for announcement, publication or distribution, directly or indirectly, in or into the U.S., Canada, Japan, Hong Kong, New Zealand, South Africa or Australia. The prospectus regarding the admission to trading of newly issued shares in Moberg Pharma AB (publ)(STO:MOB) is now available on the company’s website www.mobergpharma.se and in the company’s offices, at Gustavslundsvägen 42, 167 51 Bromma. Documents incorporated by reference in the prospectus are also available in accordance with the above.